BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 34613786)

  • 21. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
    Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE
    J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.
    Yamamoto M; Kiso M; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Takeda M; Kinoshita N; Ohmagari N; Gohda J; Semba K; Matsuda Z; Kawaguchi Y; Kawaoka Y; Inoue JI
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
    Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
    Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
    ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.
    Reuter N; Chen X; Kropff B; Peter AS; Britt WJ; Mach M; Überla K; Thomas M
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
    Bestle D; Heindl MR; Limburg H; Van Lam van T; Pilgram O; Moulton H; Stein DA; Hardes K; Eickmann M; Dolnik O; Rohde C; Klenk HD; Garten W; Steinmetzer T; Böttcher-Friebertshäuser E
    Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32703818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
    Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
    Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
    Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2.
    Roy AV; Chan M; Banadyga L; He S; Zhu W; Chrétien M; Mbikay M
    Virol J; 2024 Jan; 21(1):29. PubMed ID: 38273400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.